450 related articles for article (PubMed ID: 33197277)
1. Epigenetic regulation of cancer stem cell formation and maintenance.
French R; Pauklin S
Int J Cancer; 2021 Jun; 148(12):2884-2897. PubMed ID: 33197277
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic approaches targeting cancer stem cells.
Pan Y; Ma S; Cao K; Zhou S; Zhao A; Li M; Qian F; Zhu C
J Cancer Res Ther; 2018; 14(7):1469-1475. PubMed ID: 30589025
[TBL] [Abstract][Full Text] [Related]
3. Epigenetics in cancer stem cells.
Toh TB; Lim JJ; Chow EK
Mol Cancer; 2017 Feb; 16(1):29. PubMed ID: 28148257
[TBL] [Abstract][Full Text] [Related]
4. Stem cell programs in cancer initiation, progression, and therapy resistance.
Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
[TBL] [Abstract][Full Text] [Related]
5. The Metaboloepigenetic Dimension of Cancer Stem Cells: Evaluating the Market Potential for New Metabostemness-Targeting Oncology Drugs.
Menendez JA
Curr Pharm Des; 2015; 21(25):3644-53. PubMed ID: 26166605
[TBL] [Abstract][Full Text] [Related]
6. Current understanding of epigenetics mechanism as a novel target in reducing cancer stem cells resistance.
Keyvani-Ghamsari S; Khorsandi K; Rasul A; Zaman MK
Clin Epigenetics; 2021 May; 13(1):120. PubMed ID: 34051847
[TBL] [Abstract][Full Text] [Related]
7. Metal carcinogen exposure induces cancer stem cell-like property through epigenetic reprograming: A novel mechanism of metal carcinogenesis.
Wang Z; Yang C
Semin Cancer Biol; 2019 Aug; 57():95-104. PubMed ID: 30641125
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic approach of Cancer stem cells (CSCs) in gastric adenocarcinoma; DNA methyltransferases enzymes in cancer targeted therapy.
Norollahi SE; Mansour-Ghanaei F; Joukar F; Ghadarjani S; Mojtahedi K; Gharaei Nejad K; Hemmati H; Gharibpoor F; Khaksar R; Samadani AA
Biomed Pharmacother; 2019 Jul; 115():108958. PubMed ID: 31075731
[TBL] [Abstract][Full Text] [Related]
9. Loss of insulin-like growth factor II imprinting is a hallmark associated with enhanced chemo/radiotherapy resistance in cancer stem cells.
Zhao X; Liu X; Wang G; Wen X; Zhang X; Hoffman AR; Li W; Hu JF; Cui J
Oncotarget; 2016 Aug; 7(32):51349-51364. PubMed ID: 27275535
[TBL] [Abstract][Full Text] [Related]
10. [Epigenetics in cancer stem cells].
Xu LF; Zhang J; Tian ZQ; Wu YZ
Yi Chuan; 2013 Sep; 35(9):1049-57. PubMed ID: 24400477
[TBL] [Abstract][Full Text] [Related]
11. Evolving Strategies for Therapeutically Targeting Cancer Stem Cells.
Talukdar S; Emdad L; Das SK; Sarkar D; Fisher PB
Adv Cancer Res; 2016; 131():159-91. PubMed ID: 27451127
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic Modifications and Head and Neck Cancer: Implications for Tumor Progression and Resistance to Therapy.
Castilho RM; Squarize CH; Almeida LO
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28704968
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic Targets and their Inhibitors in Cancer Therapy.
Zhao L; Duan YT; Lu P; Zhang ZJ; Zheng XK; Wang JL; Feng WS
Curr Top Med Chem; 2018; 18(28):2395-2419. PubMed ID: 30582481
[TBL] [Abstract][Full Text] [Related]
14. Cancer Stem Cells Equipped with Powerful Hedgehog Signaling and Better Epigenetic Memory: Avenues to Look for Cancer Therapeutics.
Tandon I; Waghmode A; Sharma NK
Curr Cancer Drug Targets; 2019; 19(11):877-884. PubMed ID: 31393247
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic alterations involved in cancer stem cell reprogramming.
Muñoz P; Iliou MS; Esteller M
Mol Oncol; 2012 Dec; 6(6):620-36. PubMed ID: 23141800
[TBL] [Abstract][Full Text] [Related]
16. Understanding and targeting cancer stem cells: therapeutic implications and challenges.
Chen K; Huang YH; Chen JL
Acta Pharmacol Sin; 2013 Jun; 34(6):732-40. PubMed ID: 23685952
[TBL] [Abstract][Full Text] [Related]
17. Distinct epigenetic regulation of tumor suppressor genes in putative cancer stem cells of solid tumors.
Yasuda H; Soejima K; Watanabe H; Kawada I; Nakachi I; Yoda S; Nakayama S; Satomi R; Ikemura S; Terai H; Sato T; Suzuki S; Matsuzaki Y; Naoki K; Ishizaka A
Int J Oncol; 2010 Dec; 37(6):1537-46. PubMed ID: 21042723
[TBL] [Abstract][Full Text] [Related]
18. Regulation and signaling pathways in cancer stem cells: implications for targeted therapy for cancer.
Zeng Z; Fu M; Hu Y; Wei Y; Wei X; Luo M
Mol Cancer; 2023 Oct; 22(1):172. PubMed ID: 37853437
[TBL] [Abstract][Full Text] [Related]
19. Apoptotic and autophagic pathways with relevant small-molecule compounds, in cancer stem cells.
Zhang L; Tong X; Li J; Huang Y; Hu X; Chen Y; Huang J; Wang J; Liu B
Cell Prolif; 2015 Aug; 48(4):385-97. PubMed ID: 26013704
[TBL] [Abstract][Full Text] [Related]
20. Glabridin inhibits cancer stem cell-like properties of human breast cancer cells: An epigenetic regulation of miR-148a/SMAd2 signaling.
Jiang F; Li Y; Mu J; Hu C; Zhou M; Wang X; Si L; Ning S; Li Z
Mol Carcinog; 2016 May; 55(5):929-40. PubMed ID: 25980823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
